1. Home
  2. CIX vs IMMP Comparison

CIX vs IMMP Comparison

Compare CIX & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CIX
  • IMMP
  • Stock Information
  • Founded
  • CIX 1993
  • IMMP 1987
  • Country
  • CIX United States
  • IMMP Australia
  • Employees
  • CIX N/A
  • IMMP N/A
  • Industry
  • CIX Industrial Machinery/Components
  • IMMP Biotechnology: Pharmaceutical Preparations
  • Sector
  • CIX Consumer Discretionary
  • IMMP Health Care
  • Exchange
  • CIX Nasdaq
  • IMMP Nasdaq
  • Market Cap
  • CIX 258.7M
  • IMMP 211.1M
  • IPO Year
  • CIX 1998
  • IMMP N/A
  • Fundamental
  • Price
  • CIX $25.04
  • IMMP $1.54
  • Analyst Decision
  • CIX
  • IMMP Buy
  • Analyst Count
  • CIX 0
  • IMMP 2
  • Target Price
  • CIX N/A
  • IMMP $8.50
  • AVG Volume (30 Days)
  • CIX 8.6K
  • IMMP 84.6K
  • Earning Date
  • CIX 05-06-2025
  • IMMP 05-02-2025
  • Dividend Yield
  • CIX 4.73%
  • IMMP N/A
  • EPS Growth
  • CIX N/A
  • IMMP N/A
  • EPS
  • CIX 1.35
  • IMMP N/A
  • Revenue
  • CIX $145,941,000.00
  • IMMP $3,019,249.00
  • Revenue This Year
  • CIX N/A
  • IMMP N/A
  • Revenue Next Year
  • CIX N/A
  • IMMP $20.28
  • P/E Ratio
  • CIX $19.23
  • IMMP N/A
  • Revenue Growth
  • CIX N/A
  • IMMP 24.11
  • 52 Week Low
  • CIX $17.89
  • IMMP $1.32
  • 52 Week High
  • CIX $36.10
  • IMMP $3.34
  • Technical
  • Relative Strength Index (RSI)
  • CIX 62.33
  • IMMP 39.93
  • Support Level
  • CIX $19.21
  • IMMP $1.44
  • Resistance Level
  • CIX $25.90
  • IMMP $1.56
  • Average True Range (ATR)
  • CIX 1.72
  • IMMP 0.12
  • MACD
  • CIX 0.65
  • IMMP 0.00
  • Stochastic Oscillator
  • CIX 95.58
  • IMMP 41.63

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

Share on Social Networks: